You just read:

Halozyme Announces Janssen Submits BLA To FDA For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology

News provided by

Halozyme Therapeutics, Inc.

Jul 12, 2019, 11:59 ET